- Home
- Publications
- Publication Search
- Publication Details
Title
Contemporary update on neoadjuvant therapy for bladder cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume 14, Issue 6, Pages 348-358
Publisher
Springer Nature
Online
2017-03-14
DOI
10.1038/nrurol.2017.30
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
- (2017) Elizabeth R Plimack et al. LANCET ONCOLOGY
- Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder.
- (2017) U. B. Chaudhary et al. JOURNAL OF CLINICAL ONCOLOGY
- Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC).
- (2017) Arjun Vasant Balar et al. JOURNAL OF CLINICAL ONCOLOGY
- NeuACT, a phase II, randomized, open-label trial of DN24-02: Updated analysis of HER2 expression, immune responses, product parameters, and safety in patients with surgically resected HER2+ urothelial cancer.
- (2017) Dean F. Bajorin et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapies Combined With Immune Checkpoint Therapy
- (2016) Peter A. Prieto et al. CANCER JOURNAL
- Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation
- (2016) Kamran Zargar-Shoshtari et al. Clinical Genitourinary Cancer
- Chemotherapy and immunotherapy: mapping the road ahead
- (2016) Alistair M Cook et al. CURRENT OPINION IN IMMUNOLOGY
- Perioperative treatment and radical cystectomy for bladder cancer – a population based trend analysis of 10,338 patients in the Netherlands
- (2016) Tom J.N. Hermans et al. EUROPEAN JOURNAL OF CANCER
- Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer
- (2016) Charles Chuanhai Guo et al. EUROPEAN UROLOGY
- ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy
- (2016) Floris H. Groenendijk et al. EUROPEAN UROLOGY
- A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer
- (2016) David J. McConkey et al. EUROPEAN UROLOGY
- Autophagy inhibition (AI) as a novel treatment strategy in bladder cancer (BC).
- (2016) Petros Grivas et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of gemcitabine + cisplatin + ipilimumab in patients with metastatic urothelial cancer.
- (2016) Matt D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2016) Matthew I. Milowsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer
- (2016) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Bladder Cancer, Version 2.2016
- (2016) Peter E. Clark et al. Journal of the National Comprehensive Cancer Network
- Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer—Does pT0 Predict Better Survival than pTa/Tis/T1?
- (2016) Homayoun Zargar et al. JOURNAL OF UROLOGY
- Patients with an Orthotopic Low Pressure Bladder Substitute Enjoy Long-Term Good Function
- (2016) Marc A. Furrer et al. JOURNAL OF UROLOGY
- The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
- (2016) Christopher R. Haas et al. JOURNAL OF UROLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity
- (2016) Noah M. Hahn et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
- (2015) Matthew D. Galsky et al. CANCER
- Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma
- (2015) Metin Kurtoglu et al. Clinical Genitourinary Cancer
- Genetic subtypes of invasive bladder cancer
- (2015) David J. McConkey et al. CURRENT OPINION IN UROLOGY
- Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
- (2015) Homayoun Zargar et al. EUROPEAN UROLOGY
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing Tides
- (2015) Zachary D. Reardon et al. EUROPEAN UROLOGY
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- Future Directions and Targeted Therapies in Bladder Cancer
- (2015) Guru Sonpavde et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Genomic landscape of high-grade T1 micropapillary bladder tumors.
- (2015) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
- (2015) J. Tschui et al. VIRCHOWS ARCHIV
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Biological determinants of bladder cancer gene expression subtypes
- (2015) Mattias Aine et al. Scientific Reports
- Tumor Regression Grade of Urothelial Bladder Cancer After Neoadjuvant Chemotherapy
- (2014) Achim Fleischmann et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209
- (2014) H. Kitamura et al. ANNALS OF ONCOLOGY
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity
- (2014) Elizabeth R. Plimack et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates
- (2014) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
- (2014) Thomas Powles et al. NATURE
- Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
- (2014) Woonyoung Choi et al. Nature Reviews Urology
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Micropapillary bladder cancer: Current treatment patterns and review of the literature
- (2014) Daniel L. Willis et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer
- (2013) Joshua J. Meeks et al. BJU INTERNATIONAL
- Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades
- (2013) Pascal Zehnder et al. BJU INTERNATIONAL
- Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients
- (2013) R. Houston Thompson et al. BJU INTERNATIONAL
- Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity
- (2013) David C. Johnson et al. BJU INTERNATIONAL
- Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis
- (2013) Fausto Petrelli et al. EUROPEAN UROLOGY
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
- (2013) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
- (2013) Jeffrey J. Leow et al. EUROPEAN UROLOGY
- Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer
- (2013) Gopa Iyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Rationale for Chemotherapy, Immunotherapy, and Checkpoint Blockade in SCLC: Beyond Traditional Treatment Approaches
- (2013) David R. Spigel et al. Journal of Thoracic Oncology
- Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
- (2013) Stephen H. Culp et al. JOURNAL OF UROLOGY
- Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
- (2013) Guangwu Guo et al. NATURE GENETICS
- Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience
- (2012) Faysal A. Yafi et al. BJU INTERNATIONAL
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 Patients
- (2012) Richard E. Hautmann et al. EUROPEAN UROLOGY
- Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center
- (2012) Siobhan P. Lynch et al. EUROPEAN UROLOGY
- Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting
- (2012) Andrea B. Apolo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
- (2012) Adrian S. Fairey et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
- (2011) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy
- (2011) Firas Abdollah et al. BJU INTERNATIONAL
- Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
- (2011) Robert S. Svatek et al. BJU INTERNATIONAL
- A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer
- (2011) Matthew S. Wosnitzer et al. CANCER
- Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours
- (2011) Achim Fleischmann et al. EUROPEAN UROLOGY
- Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
- (2011) Robert Rosenblatt et al. EUROPEAN UROLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
- (2011) Matthew D Galsky et al. LANCET ONCOLOGY
- Neoadjuvant Systemic Therapy or Early Cystectomy? Single-center Analysis of Outcomes After Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder
- (2011) Islam A. Ghoneim et al. UROLOGY
- A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results
- (2010) Raj S. Pruthi et al. BJU INTERNATIONAL
- The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder
- (2010) R. S. Svatek et al. CLINICAL CANCER RESEARCH
- Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
- (2010) B. C. Carthon et al. CLINICAL CANCER RESEARCH
- Baseline Renal Function Status Limits Patient Eligibility to Receive Perioperative Chemotherapy for Invasive Bladder Cancer and Is Minimally Affected by Radical Cystectomy
- (2010) Daniel Canter et al. UROLOGY
- Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy
- (2009) Guru Sonpavde et al. CANCER
- A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder
- (2008) Atreya Dash et al. CANCER
- Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience
- (2008) S. Machele Donat et al. EUROPEAN UROLOGY
- Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection
- (2008) Nivedita Bhatta Dhar et al. JOURNAL OF UROLOGY
- Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience
- (2008) Tanya B. Dorff et al. WORLD JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More